|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | (2013.01) |
| C07D 401/14 | (2006.01) | ||
| C07D 403/14 | (2006.01) | ||
| A61K 31/444 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61P 5/48 | (2006.01) | ||
| C07D 403/14 | (2013.01) | ||
| A61K 31/7008 | (2013.01) | ||
| C07D 417/14 | (2013.01) | ||
| A61K 31/155 | (2013.01) | ||
| A61K 31/351 | (2013.01) | ||
| A61K 31/397 | (2013.01) | ||
| C07D 487/10 | (2013.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 5/48 | (2018.01) |
| (11) | Number of the document | 3585775 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18707874.6 |
| Date of filing the European patent application | 2018-02-20 | |
| (97) | Date of publication of the European application | 2020-01-01 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/054133 |
| Date | 2018-02-20 |
| (87) | Number | WO 2018/153849 |
| Date | 2018-08-30 |
| (30) | Number | Date | Country code |
| 17305189 | 2017-02-21 | EP |
| (72) |
SCHWINK, Lothar , DE
BUNING, Christian , DE
GLOMBIK, Heiner , DE
PÖVERLEIN, Christoph , DE
RITTER, Kurt , DE
HALLAND, Nis , DE
LOHMANN, Matthias , DE
|
| (73) |
Sanofi ,
54, rue La Boétie, 75008 Paris,
FR
|
| (54) | AZETIDINE COMPOUNDS AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS |
| AZETIDINE COMPOUNDS AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS |